Hoff PM - Search Results

1

Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community.

Protásio BM, Matutino A, Lage LV, Santana I, Ramos R, Sabbaga J, Capareli F, Saragiotto D, Riechelmann R, Hoff PM. Protásio BM, et al. Among authors: hoff pm. Clin Colorectal Cancer. 2017 Mar;16(1):65-72. doi: 10.1016/j.clcc.2016.07.001. Epub 2016 Jul 19. Clin Colorectal Cancer. 2017. PMID: 27515842

2

Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer.

Hoff PM, Wolff RA, Xiong H, Jones D, Lin E, Eng C, Dutta A, Bogaard KR, Abbruzzese JL. Hoff PM, et al. Cancer. 2006 May 15;106(10):2241-6. doi: 10.1002/cncr.21874. Cancer. 2006. PMID: 16598762 Free article. Clinical Trial.

3

Second-line chemotherapy use in metastatic colon cancer varies by disease responsiveness.

Politano S, Overman M, Pathak P, Chadha R, Glover K, Chang DZ, Wolff RA, Hoff PM, Abbruzzese J, Eng C, Kopetz S. Politano S, et al. Among authors: hoff pm. Clin Colorectal Cancer. 2008 Jan;7(1):55-9. doi: 10.3816/CCC.2008.n.008. Clin Colorectal Cancer. 2008. PMID: 18279578

4

A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer.

Hoff PM, Kopetz S, Thomas MB, Langleben A, Rinaldi D, Anthony L, Wolff RA, Lassere Y, Abbruzzese JL. Hoff PM, et al. Br J Cancer. 2008 Sep 2;99(5):722-6. doi: 10.1038/sj.bjc.6604541. Epub 2008 Aug 12. Br J Cancer. 2008. PMID: 18728662 Free PMC article. Clinical Trial.

5

Integration of anti-vascular endothelial growth factor therapies with cytotoxic chemotherapy in the treatment of colorectal cancer.

Oliveira SC, Machado KK, Sabbaga J, Hoff PM. Oliveira SC, et al. Among authors: hoff pm. Cancer J. 2010 May-Jun;16(3):220-5. doi: 10.1097/PPO.0b013e3181ddc7c4. Cancer J. 2010. PMID: 20526100 Review.

6

Durable complete responses in metastatic colorectal cancer treated with chemotherapy alone.

Ferrarotto R, Pathak P, Maru D, Agarwal A, Overman M, Hoff PM, Kopetz S. Ferrarotto R, et al. Among authors: hoff pm. Clin Colorectal Cancer. 2011 Sep;10(3):178-82. doi: 10.1016/j.clcc.2011.03.023. Epub 2011 Apr 24. Clin Colorectal Cancer. 2011. PMID: 21855039

7

Literature review and practical aspects on the management of oxaliplatin-associated toxicity.

Hoff PM, Saad ED, Costa F, Coutinho AK, Caponero R, Prolla G, Gansl RC. Hoff PM, et al. Clin Colorectal Cancer. 2012 Jun;11(2):93-100. doi: 10.1016/j.clcc.2011.10.004. Epub 2011 Dec 6. Clin Colorectal Cancer. 2012. PMID: 22154408 Review.

8

Bevacizumab: overview of the literature.

Braghiroli MI, Sabbaga J, Hoff PM. Braghiroli MI, et al. Among authors: hoff pm. Expert Rev Anticancer Ther. 2012 May;12(5):567-80. doi: 10.1586/era.12.13. Expert Rev Anticancer Ther. 2012. PMID: 22594892 Review.

9

Antiangiogenic drugs for colorectal cancer: exploring new possibilities.

Ferrarotto R, Hoff PM. Ferrarotto R, et al. Among authors: hoff pm. Clin Colorectal Cancer. 2013 Mar;12(1):1-7. doi: 10.1016/j.clcc.2012.06.002. Epub 2012 Jul 3. Clin Colorectal Cancer. 2013. PMID: 22763196 Review.

10

Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).

Hoff PM, Hochhaus A, Pestalozzi BC, Tebbutt NC, Li J, Kim TW, Koynov KD, Kurteva G, Pintér T, Cheng Y, van Eyll B, Pike L, Fielding A, Robertson JD, Saunders MP. Hoff PM, et al. J Clin Oncol. 2012 Oct 10;30(29):3596-603. doi: 10.1200/JCO.2012.42.6031. Epub 2012 Sep 10. J Clin Oncol. 2012. PMID: 22965965 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters